Reassessment of mast cell stabilizers in the treatment of respiratory disease.
Church
M K
MK
Immunopharmacology Group, Southampton General Hospital, United Kingdom.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000818:Animals; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology; D002648:Child; D002986:Clinical Trials as Topic; D004205:Cromolyn Sodium / Q000627:therapeutic use; D006633:Histamine Antagonists / Q000627:therapeutic use*; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D008407:Mast Cells / Q000187:drug effects*; D017835:Nedocromil; D015363:Quinolones / Q000627:therapeutic use; D051381:Rats; D013806:Theophylline / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D006633:Histamine Antagonists; D015363:Quinolones; D017835:Nedocromil; D013806:Theophylline; D007545:Isoproterenol; D004205:Cromolyn Sodium